Loading clinical trials...
Loading clinical trials...
Despite anti-thymocyte globulin has a mainstay role in preventing GvHD (and non-relapse mortality) in CB transplantation, it also induces delayed immune recovery, increased risk of cytomegalovirus and...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
NCT02269592 · Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndromes, and more
NCT07472972 · Lymphoma, Lymphoid Hematological Malignancies
NCT07122674 · Hematological Malignancies
NCT06834412 · Hematological Malignancies
NCT06851702 · Hematological Malignancies
Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma, RM
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions